The Ki-67 index can significantly influence treatment strategies. For example, in breast cancer, a high Ki-67 index may lead to the consideration of more aggressive treatment options, such as chemotherapy, even if the tumor is otherwise considered to be early-stage. Conversely, a low Ki-67 index might support opting for less aggressive treatments, such as hormone therapy or surgery alone.